Alan Lam

Alan Lam has extensive experience in disease area strategy, particularly in oncology, neurology, and inflammation programs. They have held leadership roles at organizations such as AstraZeneca, where they currently serve as Global Study Director for Cell Therapy, and have previously worked at esteemed companies including Amgen, Fate Therapeutics Inc, and Genentech. Alan's expertise encompasses market research, clinical operations, KOL engagement, and data analytics. They earned a BA from the University of California, Santa Cruz, and obtained a certification from the Project Management Institute.